Lymphangioleiomyomatosis (LAM) is a slowly progressive, low-grade, metastasising
neoplasm of women, characterised by infiltration of the lung parenchyma with abnormal …

Lymphangioleiomyomatosis (LAM) is a rare progressive lung disease of women. LAM is
caused by mutations in the tuberous sclerosis genes, resulting in activation of the mTOR …

Lymphangioleiomyomatosis (LAM) is a slowly progressive lung disease that is associated
with mutations in tuberous sclerosis complex genes, infiltration of the pulmonary …

Lymphangioleiomyomatosis (LAM) is a rare disease characterised by proliferation of
abnormal smooth muscle-like cells (LAM cells) leading to progressive cystic destruction of …

Lymphangioleiomyomatosis (LAM) is a rare multisystem disease which predominantly
affects women. The disease occurs both sporadically and is common in women with …

Background: Lymphangioleiomyomatosis (LAM) is a rare cystic lung disease that primarily
affects women. The purpose of these guidelines is to provide recommendations for the …

Lymphangioleiomyomatosis (LAM) is a rare, low-grade, metastasizing neoplasm that arises
from an unknown source, spreads via the lymphatics, and targets the lungs. All pulmonary …

Lymphangioleiomyomatosis (LAM) is a progressive cystic lung disease primarily affecting
women that has historically been classified and clinically managed as a nonneoplastic …

METHODS The purpose of the LAM Task Force was to produce evidence based, consensus
guidelines for the diagnosis, assessment and treatment of patients with LAM. The two …

Lymphangioleiomyomatosis (LAM) is a multisystem disease of women, characterized by
proliferation of abnormal smooth muscle-like LAM cells, leading to the formation of lung …